2022 AIMBE Fellows

February 18, 2022

FOR IMMEDIATE RELEASE

Media Contact: Charlie Kim (service@aimbe.org)

The American Institute for Medical and Biological Engineering (AIMBE) announced today the election of 153 new members of the AIMBE College of Fellows in recognition of their distinguished and continuing achievements in medical and biological engineering.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

AIMBE Fellows are among the most distinguished medical and biological engineers including 3 Nobel Prize laureates, 18 Fellows having received the Presidential Medal of Science and/or Technology and Innovation, and 201 also inducted to the National Academy of Engineering, 101 inducted to the National Academy of Medicine and 45 inducted to the National Academy of Sciences.

2022 AIMBE Fellows:

• Fabrisia Ambrosio, Ph.D., MPT, University of Pittsburgh
• Donald D. Anderson, Ph.D., University of Iowa
• Sameer Antani, Ph.D., National Institutes of Health
• Ellen M. Arruda, Ph.D., University of Michigan
• Giorgio Ascoli, Ph.D., George Mason University
• Regina Barzilay, Ph.D., Massachusetts Institute of Technology
• Muyinatu A. Lediju Bell, Ph.D., Johns Hopkins University
• Maria J. Blanco-Prieto, Ph.D., University of Navarra
• Elliot Botvinick, Ph.D., University of California, Irvine
• Lydia Bourouiba, Ph.D., Massachusetts Institute of Technology
• Christopher L. Brace, Ph.D., University of Wisconsin–Madison
• Michael A. Caligiuri, MD, City of Hope
• Shantanu Chakrabartty, Ph.D., Washington University in St. Louis
• Rama Chellappa, Ph.D., Johns Hopkins University
• Ji Chen, Ph.D., University of Houston
• Wei R Chen, Ph.D., University of Oklahoma
• Wilfred Chen, Ph.D., University of Delaware
• Xuesi Chen, Ph.D., Chinese Academy of Sciences
• Youhai H. Chen, MD, Ph.D., University of Pennsylvania
• Jianlin Cheng, Ph.D., University of Missouri – Columbia
• Jung-Chih Chiao, Ph.D., Southern Methodist University
• Gary E. Christensen, D.Sc., University of Iowa
• Christos Constantinidis, Ph.D., Vanderbilt University
• Kenneth A. Dawson, Ph.D., University College Dublin
• Emily Day, Ph.D., University of Delaware
• Don DeVoe, Ph.D., University of Maryland, College Park
• Michelle Digman, Ph.D., University of California, Irvine
• Zhaohua Ding, Ph.D., Vanderbilt University
• Nikolay V. Dokholyan, MS, Ph.D., Penn State College of Medicine
• Yizhou Dong, Ph.D., Ohio State University
• Marina E. Emborg, MD, Ph.D., University of Wisconsin–Madison
• David Erickson, Ph.D., Cornell University
• Virginia L. Ferguson, Ph.D., University of Colorado at Boulder
• Elana J. Fertig, Ph.D., Johns Hopkins University
• Gabor Fichtinger, Dr. Univ., Queen’s University
• Bonnie L. Firestein, Ph.D., Rutgers, the State University of New Jersey
• Eric Ford, Ph.D., University of Washington
• Stephanie I. Fraley, Ph.D., University of California, San Diego
• James G. Fujimoto, Ph.D., Massachusetts Institute of Technology
• Akhilesh K. Gaharwar, Ph.D., Texas A&M University
• James Galagan, Ph.D., Boston University
• Jean Gao, Ph.D., University of Texas at Arlington
• Weiqiang Gao, Ph.D., Shanghai Jiao Tong University
• Lana X. Garmire, Ph.D., University of Michigan
• Yatin Gokarn, Ph.D., Alexion, AstraZeneca’s Rare Disease group
• Robert G. Gourdie, Ph.D., Virginia Tech
• Aysegul Gunduz, Ph.D., University of Florida
• Umut A. Gurkan, Ph.D., Case Western Reserve University
• Susan C. Hagness, Ph.D., University of Wisconsin–Madison
• Timothy J. Hall, Ph.D., University of Wisconsin–Madison
• Gang Han, Ph.D., University of Massachusetts-Medical School
• Xue Han, Ph.D., Boston University
• Levi Hargrove, Ph.D., Shirley Ryan AbilityLab
• Richard Heller, Ph.D., University of South Florida
• Monica Hinds, Ph.D., Oregon Health & Science University
• Seungpyo Hong, Ph.D., University of Wisconsin–Madison
• Risto J. Ilmoniemi, Ph.D., Aalto University
• Omer T. Inan, Ph.D., Georgia Institute of Technology
• Ricardo Izurieta, MD, DrPH, University of South Florida
• Ana Jaklenec, Ph.D., Massachusetts Institute of Technology
• Susan P. James, Ph.D., Colorado State University
• Shuiwang Ji, Ph.D., Texas A&M University
• Steve Jiang, Ph.D., University of Texas Southwestern Medical Center
• Javier A. Jo, Ph.D., University of Oklahoma
• Kevin B. Johnson, MD, MS, Vanderbilt University Medical Center
• Shella Keilholz, Ph.D., Emory University
• Paul Kinahan, Ph.D., University of Washington
• Miiri Kotche, Ph.D., University of Illinois at Chicago
• Wilbur A. Lam, MD, Ph.D., Emory University/GeorgiaTech
• Jan Lammerding, Ph.D., Cornell University
• Curtis P. Langlotz, MD, Ph.D., Stanford University
• Jason Lewis, Ph.D., Memorial Sloan Kettering Cancer Center
• Yuanpei Li, Ph.D., University of California, Davis
• Rui Liao, Ph.D., Siemens Healthineers
• Chang Liu, Ph.D., University of California, Irvine
• Chunlei Liu, Ph.D., University of California, Berkeley
• Wendy Liu, Ph.D., University of California, Irvine
• Xiaole S. Liu, Ph.D., Dana-Farber Cancer Institute / Harvard University
• Christopher Loose, Ph.D., Frequency Therapeutics
• Christine H. Lorenz, Ph.D., MBA, Cohesic, Inc.
• Ting Lu, Ph.D., University of Illinois Urbana-Champaign
• Julius B. Lucks, Ph.D., Northwestern University
• Guanghui Ma, Ph.D., Chinese Academy of Sciences
• Jian Ma, Ph.D., Carnegie Mellon University
• Prashant G. Mali, Ph.D., University of California, San Diego
• Brenda Mann, Ph.D., Kiora Pharmaceuticals
• João F. Mano, Ph.D., University of Aveiro
• Heidi M. Mansour, Ph.D., R.Ph., Florida International University
• Dejan Markovic, Ph.D., University of California, Los Angeles
• Kara E. McCloskey, Ph.D., University of California, Merced
• Subhra Mohapatra, MS, Ph.D., University of South Florida
• Ramakrishna Mukkamala, Ph.D., University of Pittsburgh
• Harriet Nembhard, Ph.D., University of Iowa
• Guangjun Nie, Ph.D., National Centre for Nanoscience and Technology
• Marcia O’Malley, Ph.D., Rice University
• Teri W. Odom, Ph.D., Northwestern University
• Angela K. Pannier, Ph.D., University of Nebraska-Lincoln
• Keshab K. Parhi, Ph.D., University of Minnesota
• Suzanne Phillips, BS, MBA, MD Anderson Cancer Center
• George D. Pins, Ph.D., Worcester Polytechnic Institute
• Darrin Pochan, Ph.D., University of Delaware
• Shalini Prasad, Ph.D., University of Texas, Dallas
• Robin Queen, Ph.D., Virginia Tech
• Sanguthevar Rajasekaran, Ph.D., University of Connecticut
• John Tilak Ratnanather, D.Phil., Johns Hopkins University
• Dacheng Ren, Ph.D., Syracuse University
• Qiaoqiao Ruan, Ph.D., Abbott
• Jeffrey W. Ruberti, Ph.D., Northeastern University
• Sandra Rugonyi, Ph.D., Oregon Health & Science University
• Krishanu Saha, Ph.D., University of Wisconsin–Madison
• Casim A. Sarkar, Ph.D., University of Minnesota
• Robert L. Satcher, Jr., MD, Ph.D., MD Anderson Cancer Center
• Mark E. Schafer, Ph.D., Drexel University
• Erik Scott, Ph.D., Medtronic
• Evan Scott, Ph.D., Northwestern University
• Puneet Sharma, Ph.D., Siemens Healthineers
• Amarda Shehu, Ph.D., George Mason University
• Daniel J. Siegwart, Ph.D., University of Texas Southwestern Medical Center
• Ankur Singh, Ph.D., Georgia Institute of Technology
• Marina Sirota, Ph.D., University of California, San Francisco
• Andrew M. Smith, Ph.D., University of Illinois Urbana-Champaign
• Kurt Smith, D.Sc., Medtronic
• Seth Smith, Ph.D., Vanderbilt University Medical Center
• Peter T. C. So, Ph.D., Massachusetts Institute of Technology
• Ram D. Sriram, Ph.D., National Institute of Standards and Technology
• Sarah E. Stabenfeldt, Ph.D., Arizona State University
• Jeanne C. Stachowiak, Ph.D., University of Texas at Austin
• Dimitrije Stamenovic, Ph.D., Boston University
• Kelly R. Stevens, Ph.D., University of Washington
• Mriganka Sur, Ph.D., Massachusetts Institute of Technology
• Julie Swann, Ph.D., North Carolina State University
• Sabine Szunerits, Ph.D., University of Lille
• Kai Yu Raymond Tong, Ph.D., The Chinese University of Hong Kong
• Ragini Verma, Ph.D., University of Pennsylvania
• Alex Vitkin, Ph.D., University of Toronto
• Pavlos P. Vlachos, Ph.D., Purdue University
• Paul W. Wacnik, Ph.D., MBA, Pfizer, Inc.
• Amy Wagoner Johnson, Ph.D., University of Illinois Urbana-Champaign
• Sharon L. Walker, Ph.D., Drexel University
• Liyun Wang, Ph.D., University of Delaware
• Meiyun Wang, MD, Ph.D., Henan Provincial People’s Hospital
• Wenyi Wei, Ph.D., Beth Israel Deaconess Medical Center
• Stephen T. Wong, Ph.D., Houston Methodist Hospital
• Pamela K. Woodard, MD, Washington University School of Medicine
• Nianqiang Wu, Ph.D., University of Massachusetts Amherst
• Tao Xin, M.S., Abbott
• Jianhua Yao, Ph.D., Tencent AI Lab
• Agnes Yeboah, Ph.D., Bristol Myers Squibb
• James J. Yoo, MD, Ph.D., Wake Forest School of Medicine
• Can Zhang, Ph.D., China Pharmaceutical University
• Hao F. Zhang, Ph.D., Northwestern University
• Pan Zheng, MD, Ph.D., OncoC4, Inc.
• Quing Zhu, Ph.D., Washington University in St Louis

ABOUT AIMBE

Established in 1991, the American Institute for Medical and Biological Engineering (AIMBE) is a non-profit organization headquartered in Washington, D.C., representing the most accomplished individuals in the fields of medical and biological engineering. No other organization can bring together academia, industry, government, and scientific societies to form a highly influential community advancing medical and biological engineering. AIMBE’s mission is to provide leadership and advocacy in medical and biological engineering for the benefit of society.